1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Broad Agency Announcement (BAA) (HR001126S0003) is sponsored by Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO). This BAA seeks high-impact, revolutionary research ideas in biological technologies that are not currently addressed by existing programs or solicitations.
It supports fundamental and applied research, including new tools, platforms, and capabilities in biotechnology with potential national security impact. Interests include AI and ML for biology, combat casualty care, and advanced biomanufacturing.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Open to all responsible sources from academia, industry, and non-profit organizations. Confirm the full requirements in the official notice before applying.
Applications for Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Broad Agency Announcement (BAA) (HR001126S0003) are due September 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Broad Agency Announcement (BAA) (HR001126S0003) is funded by Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article